Ｊ－ラクオリア創薬（4579）　RaQualia Announces Top-Line Results of Phase III clinical trial of Ziprasidone Conducted by Meiji Seika Pharma in Patients with Schizophrenia in Japan 2019/09/06
/-
読み込み中…